

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.00652107 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.00652107 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.95790721 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.95790721 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.68596833 |
| 6 | desmosome organization (GO:0002934) | 5.44077321 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.41255832 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.41255832 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.41255832 |
| 10 | cysteine metabolic process (GO:0006534) | 5.34485563 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.24719784 |
| 12 | urea cycle (GO:0000050) | 5.23026092 |
| 13 | urea metabolic process (GO:0019627) | 5.23026092 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.17428490 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.15023811 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.11577840 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 4.88724116 |
| 18 | homocysteine metabolic process (GO:0050667) | 4.70999574 |
| 19 | nitrogen cycle metabolic process (GO:0071941) | 4.70023998 |
| 20 | lysine catabolic process (GO:0006554) | 4.68965371 |
| 21 | lysine metabolic process (GO:0006553) | 4.68965371 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 4.53614499 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 4.47771455 |
| 24 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.45866455 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.43836402 |
| 26 | protein carboxylation (GO:0018214) | 4.43836402 |
| 27 | bile acid biosynthetic process (GO:0006699) | 4.40155503 |
| 28 | negative regulation of cholesterol transport (GO:0032375) | 4.30992262 |
| 29 | negative regulation of sterol transport (GO:0032372) | 4.30992262 |
| 30 | intestinal epithelial cell development (GO:0060576) | 4.30295507 |
| 31 | drug catabolic process (GO:0042737) | 4.22075067 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.21392997 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 4.20628080 |
| 34 | amino-acid betaine metabolic process (GO:0006577) | 4.20388238 |
| 35 | skin morphogenesis (GO:0043589) | 4.13641092 |
| 36 | high-density lipoprotein particle remodeling (GO:0034375) | 4.07409076 |
| 37 | drug transmembrane transport (GO:0006855) | 4.07376899 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.06657831 |
| 39 | intestinal cholesterol absorption (GO:0030299) | 4.05270421 |
| 40 | cellular ketone body metabolic process (GO:0046950) | 4.05162267 |
| 41 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.01458586 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 4.01395829 |
| 43 | urate metabolic process (GO:0046415) | 3.99919461 |
| 44 | bile acid metabolic process (GO:0008206) | 3.90983441 |
| 45 | regulation of fibrinolysis (GO:0051917) | 3.89920348 |
| 46 | complement activation, alternative pathway (GO:0006957) | 3.88276174 |
| 47 | flavonoid metabolic process (GO:0009812) | 3.87679981 |
| 48 | plasma lipoprotein particle clearance (GO:0034381) | 3.85844222 |
| 49 | cellular glucuronidation (GO:0052695) | 3.84752356 |
| 50 | serine family amino acid metabolic process (GO:0009069) | 3.83990402 |
| 51 | phospholipid efflux (GO:0033700) | 3.81779380 |
| 52 | hemidesmosome assembly (GO:0031581) | 3.79456599 |
| 53 | cellular modified amino acid catabolic process (GO:0042219) | 3.79373256 |
| 54 | regulation of protein activation cascade (GO:2000257) | 3.78706257 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 3.78633068 |
| 56 | triglyceride homeostasis (GO:0070328) | 3.75708258 |
| 57 | acylglycerol homeostasis (GO:0055090) | 3.75708258 |
| 58 | establishment of planar polarity (GO:0001736) | 3.71643096 |
| 59 | establishment of tissue polarity (GO:0007164) | 3.71643096 |
| 60 | bile acid and bile salt transport (GO:0015721) | 3.71240365 |
| 61 | intestinal absorption (GO:0050892) | 3.70907542 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 3.69999161 |
| 63 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.69891774 |
| 64 | drug transport (GO:0015893) | 3.67653828 |
| 65 | glycine metabolic process (GO:0006544) | 3.66863679 |
| 66 | reverse cholesterol transport (GO:0043691) | 3.63415491 |
| 67 | regulation of cholesterol homeostasis (GO:2000188) | 3.60876557 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 3.60684776 |
| 69 | glutamate metabolic process (GO:0006536) | 3.60210478 |
| 70 | cellular biogenic amine catabolic process (GO:0042402) | 3.60035672 |
| 71 | amine catabolic process (GO:0009310) | 3.60035672 |
| 72 | keratinocyte proliferation (GO:0043616) | 3.58881568 |
| 73 | plasma lipoprotein particle remodeling (GO:0034369) | 3.58393416 |
| 74 | protein-lipid complex remodeling (GO:0034368) | 3.58393416 |
| 75 | macromolecular complex remodeling (GO:0034367) | 3.58393416 |
| 76 | regulation of keratinocyte proliferation (GO:0010837) | 3.56911746 |
| 77 | positive regulation of lipid catabolic process (GO:0050996) | 3.56720297 |
| 78 | serine family amino acid biosynthetic process (GO:0009070) | 3.56328680 |
| 79 | glucuronate metabolic process (GO:0019585) | 3.55467579 |
| 80 | uronic acid metabolic process (GO:0006063) | 3.55467579 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.53290862 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 3.53047891 |
| 83 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.52679670 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 3.52022206 |
| 85 | regulation of complement activation (GO:0030449) | 3.50845938 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.47079374 |
| 87 | phospholipid homeostasis (GO:0055091) | 3.45617473 |
| 88 | response to nitrosative stress (GO:0051409) | 3.42997239 |
| 89 | regulation of water loss via skin (GO:0033561) | 3.41673659 |
| 90 | ketone body metabolic process (GO:1902224) | 3.39908261 |
| 91 | exogenous drug catabolic process (GO:0042738) | 3.39483824 |
| 92 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.39422266 |
| 93 | apical protein localization (GO:0045176) | 3.39361537 |
| 94 | aldehyde catabolic process (GO:0046185) | 3.35986966 |
| 95 | sterol homeostasis (GO:0055092) | 3.33861170 |
| 96 | tyrosine metabolic process (GO:0006570) | 3.33214749 |
| 97 | cholesterol efflux (GO:0033344) | 3.33080501 |
| 98 | acute-phase response (GO:0006953) | 3.32618671 |
| 99 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.32238795 |
| 100 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.30680791 |
| 101 | lipoprotein metabolic process (GO:0042157) | 3.30323799 |
| 102 | cholesterol homeostasis (GO:0042632) | 3.30147550 |
| 103 | epithelial cell-cell adhesion (GO:0090136) | 3.29261431 |
| 104 | arginine metabolic process (GO:0006525) | 3.27659904 |
| 105 | carnitine metabolic process (GO:0009437) | 3.26768310 |
| 106 | fibrinolysis (GO:0042730) | 3.24883906 |
| 107 | gap junction assembly (GO:0016264) | 3.20585444 |
| 108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.19933282 |
| 109 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.19933282 |
| 110 | 2-oxoglutarate metabolic process (GO:0006103) | 3.19334125 |
| 111 | lateral sprouting from an epithelium (GO:0060601) | 3.18184896 |
| 112 | protein-lipid complex assembly (GO:0065005) | 3.17900624 |
| 113 | tight junction assembly (GO:0070830) | 3.16768676 |
| 114 | multicellular organismal water homeostasis (GO:0050891) | 3.16452968 |
| 115 | positive regulation of pseudopodium assembly (GO:0031274) | 3.16198403 |
| 116 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.15860914 |
| 117 | renal filtration (GO:0097205) | 3.15240446 |
| 118 | imidazole-containing compound metabolic process (GO:0052803) | 3.14474335 |
| 119 | regulation of bile acid biosynthetic process (GO:0070857) | 3.14302135 |
| 120 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.13870226 |
| 121 | valine metabolic process (GO:0006573) | 3.13861402 |
| 122 | drug metabolic process (GO:0017144) | 3.11812117 |
| 123 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.10630659 |
| 124 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 3.10621804 |
| 125 | acetyl-CoA metabolic process (GO:0006084) | 3.08846455 |
| 126 | short-chain fatty acid metabolic process (GO:0046459) | 3.07564659 |
| 127 | regulation of keratinocyte differentiation (GO:0045616) | 3.05542477 |
| 128 | organic acid catabolic process (GO:0016054) | 3.03779463 |
| 129 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.01424618 |
| 130 | glomerular filtration (GO:0003094) | 2.93072010 |
| 131 | asymmetric protein localization (GO:0008105) | 2.92775453 |
| 132 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.87101271 |
| 133 | midgut development (GO:0007494) | 2.86212020 |
| 134 | renal system process involved in regulation of blood volume (GO:0001977) | 2.84869613 |
| 135 | notochord development (GO:0030903) | 2.84293999 |
| 136 | limb bud formation (GO:0060174) | 2.83961779 |
| 137 | protein retention in ER lumen (GO:0006621) | 2.83777773 |
| 138 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.83509339 |
| 139 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 2.82857350 |
| 140 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.82499397 |
| 141 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.82499397 |
| 142 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.82474134 |
| 143 | surfactant homeostasis (GO:0043129) | 2.82115781 |
| 144 | establishment of skin barrier (GO:0061436) | 2.80307024 |
| 145 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.79060141 |
| 146 | endothelial cell chemotaxis (GO:0035767) | 2.78635213 |
| 147 | cochlea morphogenesis (GO:0090103) | 2.75969999 |
| 148 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.75888034 |
| 149 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.74645839 |
| 150 | cell-cell junction assembly (GO:0007043) | 2.71865611 |
| 151 | cell adhesion mediated by integrin (GO:0033627) | 2.69589331 |
| 152 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.68502606 |
| 153 | sodium ion export (GO:0071436) | 2.68437313 |
| 154 | regulation of establishment of planar polarity (GO:0090175) | 2.67541089 |
| 155 | auditory receptor cell differentiation (GO:0042491) | 2.67498151 |
| 156 | cellular protein complex localization (GO:0034629) | 2.66516011 |
| 157 | oligosaccharide biosynthetic process (GO:0009312) | 2.65332968 |
| 158 | establishment of apical/basal cell polarity (GO:0035089) | 2.64561921 |
| 159 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.62750074 |
| 160 | regulation of pseudopodium assembly (GO:0031272) | 2.61423321 |
| 161 | O-glycan processing (GO:0016266) | 2.60648101 |
| 162 | regulation of vitamin metabolic process (GO:0030656) | 2.60432078 |
| 163 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.60172160 |
| 164 | angiotensin maturation (GO:0002003) | 2.59694894 |
| 165 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.58800620 |
| 166 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.55084072 |
| 167 | negative regulation of epidermis development (GO:0045683) | 2.52537537 |
| 168 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.52515606 |
| 169 | semaphorin-plexin signaling pathway (GO:0071526) | 2.52167872 |
| 170 | water homeostasis (GO:0030104) | 2.51790498 |
| 171 | ear development (GO:0043583) | 2.49262160 |
| 172 | polarized epithelial cell differentiation (GO:0030859) | 2.49130386 |
| 173 | vitamin transmembrane transport (GO:0035461) | 2.47098309 |
| 174 | trophectodermal cell differentiation (GO:0001829) | 2.46424448 |
| 175 | regulation of epidermal cell differentiation (GO:0045604) | 2.46214721 |
| 176 | chemical homeostasis within a tissue (GO:0048875) | 2.45788066 |
| 177 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.44908148 |
| 178 | protein complex localization (GO:0031503) | 2.41137536 |
| 179 | regulation of guanylate cyclase activity (GO:0031282) | 2.39074202 |
| 180 | COPI coating of Golgi vesicle (GO:0048205) | 2.38345642 |
| 181 | Golgi transport vesicle coating (GO:0048200) | 2.38345642 |
| 182 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.36148135 |
| 183 | membrane protein ectodomain proteolysis (GO:0006509) | 2.35345356 |
| 184 | adhesion of symbiont to host cell (GO:0044650) | 2.34595653 |
| 185 | virion attachment to host cell (GO:0019062) | 2.34595653 |
| 186 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.34559013 |
| 187 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.33446830 |
| 188 | amyloid precursor protein catabolic process (GO:0042987) | 2.33317466 |
| 189 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.33122120 |
| 190 | ectodermal placode formation (GO:0060788) | 2.29449101 |
| 191 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.28125268 |
| 192 | regulation of epidermis development (GO:0045682) | 2.27735447 |
| 193 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.27601460 |
| 194 | ephrin receptor signaling pathway (GO:0048013) | 2.27383205 |
| 195 | non-canonical Wnt signaling pathway (GO:0035567) | 2.26318703 |
| 196 | chronic inflammatory response (GO:0002544) | 2.25941750 |
| 197 | hippo signaling (GO:0035329) | 2.25549366 |
| 198 | lens morphogenesis in camera-type eye (GO:0002089) | 2.24776838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.90571703 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.56040050 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.94409870 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.21779138 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.50118334 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.16732898 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.12079001 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.44862136 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.24606544 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.09927308 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.03737316 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.52621405 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45304808 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.37354701 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.34666486 |
| 16 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.21500135 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.19357629 |
| 18 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.17113150 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.12106860 |
| 20 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.04042362 |
| 21 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.01803693 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.99350253 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.97104435 |
| 24 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.96751102 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88708499 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.88370497 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.81907758 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.67842096 |
| 29 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.67327584 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.67066809 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66400931 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.65644827 |
| 33 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.65408550 |
| 34 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.61615958 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.58114476 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55913356 |
| 37 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.55875988 |
| 38 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.55591821 |
| 39 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.49236711 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47865151 |
| 41 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.47290080 |
| 42 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.42094508 |
| 43 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.42030636 |
| 44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.41662469 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40680957 |
| 46 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.39274286 |
| 47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.37034480 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36266639 |
| 49 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.35592983 |
| 50 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33241222 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.32044769 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29280374 |
| 53 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28918185 |
| 54 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28691768 |
| 55 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.26779327 |
| 56 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.25521125 |
| 57 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25308417 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23773690 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23359659 |
| 60 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.21809928 |
| 61 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21637640 |
| 62 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.21566511 |
| 63 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20430455 |
| 64 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.19356969 |
| 65 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.18060217 |
| 66 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.15196049 |
| 67 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14468660 |
| 68 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13840293 |
| 69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13439937 |
| 70 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13155226 |
| 71 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12922398 |
| 72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10536681 |
| 73 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10061201 |
| 74 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10047301 |
| 75 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09442206 |
| 76 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.08975975 |
| 77 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08679399 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07139095 |
| 79 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.05894657 |
| 80 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.04897564 |
| 81 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04860455 |
| 82 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04442884 |
| 83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03996644 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03471898 |
| 85 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02759448 |
| 86 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.02543452 |
| 87 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.02028064 |
| 88 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.00657342 |
| 89 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99414517 |
| 90 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99154999 |
| 91 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97520125 |
| 92 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97271150 |
| 93 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.96953255 |
| 94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96663283 |
| 95 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.96618394 |
| 96 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96538089 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96297868 |
| 98 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92042716 |
| 99 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91770324 |
| 100 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.91123197 |
| 101 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90502001 |
| 102 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90307636 |
| 103 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.89947841 |
| 104 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.89788413 |
| 105 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.89150872 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87048672 |
| 107 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86609701 |
| 108 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84848911 |
| 109 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.84711154 |
| 110 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.84595743 |
| 111 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.83942690 |
| 112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83332840 |
| 113 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83028606 |
| 114 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82438595 |
| 115 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80503402 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78952525 |
| 117 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.77351683 |
| 118 | MYC_22102868_ChIP-Seq_BL_Human | 0.76768858 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.74991215 |
| 120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74321142 |
| 121 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.73933413 |
| 122 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73911453 |
| 123 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.73873070 |
| 124 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.73556396 |
| 125 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.73556396 |
| 126 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.73556396 |
| 127 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.73215447 |
| 128 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.72348211 |
| 129 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.72126682 |
| 130 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.71670243 |
| 131 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.71445233 |
| 132 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.71095889 |
| 133 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.69764930 |
| 134 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.68534369 |
| 135 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.67451988 |
| 136 | GATA1_22025678_ChIP-Seq_K562_Human | 0.65661296 |
| 137 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.64611842 |
| 138 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.64038458 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.63793796 |
| 140 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.63720063 |
| 141 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.63531193 |
| 142 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.63531193 |
| 143 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63145930 |
| 144 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.62519994 |
| 145 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.62327207 |
| 146 | MAF_26560356_Chip-Seq_TH1_Human | 0.62160522 |
| 147 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60860675 |
| 148 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60841176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.86673889 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.78231278 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.94250814 |
| 4 | MP0005365_abnormal_bile_salt | 4.58508190 |
| 5 | MP0000566_synostosis | 3.92186376 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.76997486 |
| 7 | MP0000537_abnormal_urethra_morphology | 3.20355896 |
| 8 | MP0003252_abnormal_bile_duct | 3.19895986 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.09650545 |
| 10 | MP0003195_calcinosis | 2.66117791 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.65503831 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.53508122 |
| 13 | MP0003941_abnormal_skin_development | 2.47367642 |
| 14 | MP0010678_abnormal_skin_adnexa | 2.35439636 |
| 15 | MP0005332_abnormal_amino_acid | 2.33847702 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.32869591 |
| 17 | MP0009840_abnormal_foam_cell | 2.31285643 |
| 18 | MP0000762_abnormal_tongue_morphology | 2.24097198 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.23559420 |
| 20 | MP0005257_abnormal_intraocular_pressure | 2.21883620 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.16525515 |
| 22 | MP0010030_abnormal_orbit_morphology | 2.04961908 |
| 23 | MP0005083_abnormal_biliary_tract | 1.97690432 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 1.97394886 |
| 25 | MP0000462_abnormal_digestive_system | 1.97372891 |
| 26 | MP0003303_peritoneal_inflammation | 1.91425535 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.90349937 |
| 28 | MP0000467_abnormal_esophagus_morphology | 1.87304790 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 1.85057414 |
| 30 | MP0000609_abnormal_liver_physiology | 1.84602086 |
| 31 | MP0000383_abnormal_hair_follicle | 1.83616726 |
| 32 | MP0004858_abnormal_nervous_system | 1.82531680 |
| 33 | MP0005409_darkened_coat_color | 1.77830082 |
| 34 | MP0002254_reproductive_system_inflammat | 1.63801136 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.62450471 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.56990464 |
| 37 | MP0002249_abnormal_larynx_morphology | 1.55663996 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.55519311 |
| 39 | MP0002118_abnormal_lipid_homeostasis | 1.54399436 |
| 40 | MP0001346_abnormal_lacrimal_gland | 1.54117512 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.52163862 |
| 42 | MP0003315_abnormal_perineum_morphology | 1.50191041 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 1.45943319 |
| 44 | MP0003436_decreased_susceptibility_to | 1.40554822 |
| 45 | MP0002060_abnormal_skin_morphology | 1.40448548 |
| 46 | MP0003868_abnormal_feces_composition | 1.39897881 |
| 47 | MP0005451_abnormal_body_composition | 1.36329069 |
| 48 | MP0001188_hyperpigmentation | 1.36315861 |
| 49 | MP0010771_integument_phenotype | 1.35061224 |
| 50 | MP0004272_abnormal_basement_membrane | 1.33435662 |
| 51 | MP0001664_abnormal_digestion | 1.32813753 |
| 52 | MP0003186_abnormal_redox_activity | 1.29805820 |
| 53 | MP0002234_abnormal_pharynx_morphology | 1.27843196 |
| 54 | MP0005248_abnormal_Harderian_gland | 1.26997216 |
| 55 | MP0000534_abnormal_ureter_morphology | 1.23792486 |
| 56 | MP0003755_abnormal_palate_morphology | 1.21350889 |
| 57 | MP0002896_abnormal_bone_mineralization | 1.21333606 |
| 58 | MP0004957_abnormal_blastocyst_morpholog | 1.17700623 |
| 59 | MP0003693_abnormal_embryo_hatching | 1.16608248 |
| 60 | MP0002697_abnormal_eye_size | 1.15104605 |
| 61 | MP0001764_abnormal_homeostasis | 1.14902405 |
| 62 | MP0000049_abnormal_middle_ear | 1.13609264 |
| 63 | MP0009764_decreased_sensitivity_to | 1.13437725 |
| 64 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12506886 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.11177045 |
| 66 | MP0002796_impaired_skin_barrier | 1.11171211 |
| 67 | MP0000598_abnormal_liver_morphology | 1.10037024 |
| 68 | MP0005636_abnormal_mineral_homeostasis | 1.08743474 |
| 69 | MP0005076_abnormal_cell_differentiation | 1.04685673 |
| 70 | MP0002089_abnormal_postnatal_growth/wei | 1.04343798 |
| 71 | MP0004947_skin_inflammation | 1.01667269 |
| 72 | MP0009379_abnormal_foot_pigmentation | 1.01185053 |
| 73 | MP0009278_abnormal_bone_marrow | 1.00487711 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 0.99631738 |
| 75 | MP0005408_hypopigmentation | 0.99611392 |
| 76 | MP0008469_abnormal_protein_level | 0.99454773 |
| 77 | MP0003938_abnormal_ear_development | 0.99144218 |
| 78 | MP0000778_abnormal_nervous_system | 0.98807947 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.98698257 |
| 80 | MP0004270_analgesia | 0.98275896 |
| 81 | MP0005623_abnormal_meninges_morphology | 0.98062940 |
| 82 | MP0005275_abnormal_skin_tensile | 0.97939269 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.97157130 |
| 84 | MP0004043_abnormal_pH_regulation | 0.96604504 |
| 85 | MP0003937_abnormal_limbs/digits/tail_de | 0.95672798 |
| 86 | MP0005023_abnormal_wound_healing | 0.95571259 |
| 87 | MP0010155_abnormal_intestine_physiology | 0.95379713 |
| 88 | MP0002233_abnormal_nose_morphology | 0.94574643 |
| 89 | MP0000428_abnormal_craniofacial_morphol | 0.94221987 |
| 90 | MP0003091_abnormal_cell_migration | 0.94114755 |
| 91 | MP0002098_abnormal_vibrissa_morphology | 0.92159980 |
| 92 | MP0000432_abnormal_head_morphology | 0.91845998 |
| 93 | MP0001849_ear_inflammation | 0.90108177 |
| 94 | MP0005381_digestive/alimentary_phenotyp | 0.88168203 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.87267440 |
| 96 | MP0009053_abnormal_anal_canal | 0.87163799 |
| 97 | MP0005187_abnormal_penis_morphology | 0.85749301 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.84803019 |
| 99 | MP0002111_abnormal_tail_morphology | 0.83758416 |
| 100 | MP0009697_abnormal_copulation | 0.83532737 |
| 101 | MP0009763_increased_sensitivity_to | 0.82891620 |
| 102 | MP0003115_abnormal_respiratory_system | 0.81291152 |
| 103 | MP0001756_abnormal_urination | 0.81137132 |
| 104 | MP0000613_abnormal_salivary_gland | 0.81126894 |
| 105 | MP0003136_yellow_coat_color | 0.81015342 |
| 106 | MP0003283_abnormal_digestive_organ | 0.79302126 |
| 107 | MP0006082_CNS_inflammation | 0.79243058 |
| 108 | MP0004885_abnormal_endolymph | 0.78235995 |
| 109 | MP0009642_abnormal_blood_homeostasis | 0.78165855 |
| 110 | MP0005220_abnormal_exocrine_pancreas | 0.78031149 |
| 111 | MP0005464_abnormal_platelet_physiology | 0.77725345 |
| 112 | MP0003724_increased_susceptibility_to | 0.77158120 |
| 113 | MP0003935_abnormal_craniofacial_develop | 0.77071099 |
| 114 | MP0009785_altered_susceptibility_to | 0.76245918 |
| 115 | MP0001881_abnormal_mammary_gland | 0.76055038 |
| 116 | MP0000647_abnormal_sebaceous_gland | 0.75963028 |
| 117 | MP0002092_abnormal_eye_morphology | 0.75652720 |
| 118 | MP0009250_abnormal_appendicular_skeleto | 0.74501822 |
| 119 | MP0003942_abnormal_urinary_system | 0.74315680 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.73641917 |
| 121 | MP0002282_abnormal_trachea_morphology | 0.73379559 |
| 122 | MP0009672_abnormal_birth_weight | 0.73356452 |
| 123 | MP0001243_abnormal_dermal_layer | 0.72350685 |
| 124 | MP0005503_abnormal_tendon_morphology | 0.72003666 |
| 125 | MP0008932_abnormal_embryonic_tissue | 0.71823004 |
| 126 | MP0000427_abnormal_hair_cycle | 0.71575813 |
| 127 | MP0002085_abnormal_embryonic_tissue | 0.71507974 |
| 128 | MP0002116_abnormal_craniofacial_bone | 0.71459342 |
| 129 | MP0002877_abnormal_melanocyte_morpholog | 0.71417634 |
| 130 | MP0000579_abnormal_nail_morphology | 0.70057144 |
| 131 | MP0005508_abnormal_skeleton_morphology | 0.69973246 |
| 132 | MP0005025_abnormal_response_to | 0.69610824 |
| 133 | MP0001216_abnormal_epidermal_layer | 0.69229590 |
| 134 | MP0005197_abnormal_uvea_morphology | 0.68825647 |
| 135 | MP0005166_decreased_susceptibility_to | 0.68742130 |
| 136 | MP0005647_abnormal_sex_gland | 0.68214846 |
| 137 | MP0000470_abnormal_stomach_morphology | 0.67565725 |
| 138 | MP0005084_abnormal_gallbladder_morpholo | 0.67549465 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.66771824 |
| 140 | MP0001286_abnormal_eye_development | 0.66357763 |
| 141 | MP0000678_abnormal_parathyroid_gland | 0.66244336 |
| 142 | MP0002419_abnormal_innate_immunity | 0.65977191 |
| 143 | MP0001765_abnormal_ion_homeostasis | 0.65460575 |
| 144 | MP0001542_abnormal_bone_strength | 0.64976170 |
| 145 | MP0001873_stomach_inflammation | 0.64064431 |
| 146 | MP0002078_abnormal_glucose_homeostasis | 0.64025889 |
| 147 | MP0000490_abnormal_crypts_of | 0.63934464 |
| 148 | MP0005058_abnormal_lysosome_morphology | 0.63736924 |
| 149 | MP0009765_abnormal_xenobiotic_induced | 0.60155791 |
| 150 | MP0004130_abnormal_muscle_cell | 0.59714124 |
| 151 | MP0001853_heart_inflammation | 0.59686292 |
| 152 | MP0000604_amyloidosis | 0.58604825 |
| 153 | MP0000377_abnormal_hair_follicle | 0.57712680 |
| 154 | MP0000477_abnormal_intestine_morphology | 0.57458430 |
| 155 | MP0000858_altered_metastatic_potential | 0.55960935 |
| 156 | MP0001545_abnormal_hematopoietic_system | 0.55118226 |
| 157 | MP0005397_hematopoietic_system_phenotyp | 0.55118226 |
| 158 | MP0003890_abnormal_embryonic-extraembry | 0.52859108 |
| 159 | MP0008873_increased_physiological_sensi | 0.52008315 |
| 160 | MP0001663_abnormal_digestive_system | 0.51641770 |
| 161 | MP0001533_abnormal_skeleton_physiology | 0.51479395 |
| 162 | MP0003075_altered_response_to | 0.50770287 |
| 163 | MP0005501_abnormal_skin_physiology | 0.50252433 |
| 164 | MP0010368_abnormal_lymphatic_system | 0.49454033 |
| 165 | MP0003566_abnormal_cell_adhesion | 0.49308368 |
| 166 | MP0005376_homeostasis/metabolism_phenot | 0.48742590 |
| 167 | MP0003221_abnormal_cardiomyocyte_apopto | 0.48209271 |
| 168 | MP0000627_abnormal_mammary_gland | 0.46879771 |
| 169 | MP0001915_intracranial_hemorrhage | 0.46158534 |
| 170 | MP0000538_abnormal_urinary_bladder | 0.46095117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.61557651 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.59904911 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.59411475 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.34838781 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 4.86487840 |
| 6 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.85025668 |
| 7 | Neonatal short-limb short stature (HP:0008921) | 4.65750011 |
| 8 | Xanthomatosis (HP:0000991) | 4.60428085 |
| 9 | Hypoglycemic coma (HP:0001325) | 4.50908370 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.30261443 |
| 11 | Epidermoid cyst (HP:0200040) | 4.06049730 |
| 12 | Hyperammonemia (HP:0001987) | 3.93230730 |
| 13 | Joint hemorrhage (HP:0005261) | 3.74939758 |
| 14 | Complement deficiency (HP:0004431) | 3.67325445 |
| 15 | Ketosis (HP:0001946) | 3.63516391 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.61385355 |
| 17 | Hyperglycinuria (HP:0003108) | 3.61076064 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.55826762 |
| 19 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.47367931 |
| 20 | Gout (HP:0001997) | 3.46510070 |
| 21 | Fat malabsorption (HP:0002630) | 3.40371980 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.38589848 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.34160321 |
| 24 | Abnormality of purine metabolism (HP:0004352) | 3.30242664 |
| 25 | Abnormality of nucleobase metabolism (HP:0010932) | 3.29962883 |
| 26 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.29403321 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.28385782 |
| 28 | Hyperlipoproteinemia (HP:0010980) | 3.26318907 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.21467971 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.20837211 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.20837211 |
| 32 | Ketoacidosis (HP:0001993) | 3.12359964 |
| 33 | Hepatocellular carcinoma (HP:0001402) | 3.08710873 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.05910479 |
| 35 | Hypoglycemic seizures (HP:0002173) | 3.05622297 |
| 36 | Hyperglycinemia (HP:0002154) | 3.03898882 |
| 37 | Atrophic scars (HP:0001075) | 3.01830127 |
| 38 | Esophageal varix (HP:0002040) | 3.00963244 |
| 39 | Flat acetabular roof (HP:0003180) | 2.98105880 |
| 40 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.96555306 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.91623035 |
| 42 | Abnormality of complement system (HP:0005339) | 2.89860629 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.89042757 |
| 44 | Myocardial infarction (HP:0001658) | 2.87145143 |
| 45 | Partial duplication of thumb phalanx (HP:0009944) | 2.83983914 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.81266934 |
| 47 | Pili torti (HP:0003777) | 2.80108878 |
| 48 | Hyperparathyroidism (HP:0000843) | 2.77135066 |
| 49 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.76774646 |
| 50 | Symptomatic seizures (HP:0011145) | 2.75992993 |
| 51 | Generalized aminoaciduria (HP:0002909) | 2.73099195 |
| 52 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.71581490 |
| 53 | Aplasia of the phalanges of the hand (HP:0009802) | 2.71581490 |
| 54 | Aplasia involving bones of the extremities (HP:0009825) | 2.71581490 |
| 55 | Vertebral hypoplasia (HP:0008417) | 2.70191570 |
| 56 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.70191570 |
| 57 | Abnormality of proline metabolism (HP:0010907) | 2.68171533 |
| 58 | Hydroxyprolinuria (HP:0003080) | 2.68171533 |
| 59 | Proximal tubulopathy (HP:0000114) | 2.63084066 |
| 60 | Hypoalphalipoproteinemia (HP:0003233) | 2.59298105 |
| 61 | Malnutrition (HP:0004395) | 2.53864237 |
| 62 | Bronchomalacia (HP:0002780) | 2.52511547 |
| 63 | Spastic diplegia (HP:0001264) | 2.52249907 |
| 64 | Partial duplication of the phalanx of hand (HP:0009999) | 2.50947022 |
| 65 | Abnormality of methionine metabolism (HP:0010901) | 2.50514045 |
| 66 | Broad metatarsal (HP:0001783) | 2.49970209 |
| 67 | Alopecia of scalp (HP:0002293) | 2.49043839 |
| 68 | Pancreatitis (HP:0001733) | 2.48398936 |
| 69 | Milia (HP:0001056) | 2.47886665 |
| 70 | Nausea (HP:0002018) | 2.45309783 |
| 71 | Abnormality of nail color (HP:0100643) | 2.45042320 |
| 72 | Curly hair (HP:0002212) | 2.44033775 |
| 73 | Thrombophlebitis (HP:0004418) | 2.40505771 |
| 74 | Hyperactive renin-angiotensin system (HP:0000841) | 2.38805590 |
| 75 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.37010319 |
| 76 | Arterial tortuosity (HP:0005116) | 2.34419481 |
| 77 | Metabolic acidosis (HP:0001942) | 2.33988486 |
| 78 | Vascular calcification (HP:0004934) | 2.32043377 |
| 79 | Vascular tortuosity (HP:0004948) | 2.31897850 |
| 80 | Hemorrhage of the eye (HP:0011885) | 2.31780539 |
| 81 | Hypochromic microcytic anemia (HP:0004840) | 2.31618463 |
| 82 | Eczematoid dermatitis (HP:0000976) | 2.30468137 |
| 83 | Hyperuricemia (HP:0002149) | 2.29694232 |
| 84 | Increased purine levels (HP:0004368) | 2.29694232 |
| 85 | Hyperbilirubinemia (HP:0002904) | 2.28884567 |
| 86 | Abnormality of renin-angiotensin system (HP:0000847) | 2.28678367 |
| 87 | Spinal cord compression (HP:0002176) | 2.27722803 |
| 88 | Delayed CNS myelination (HP:0002188) | 2.27592184 |
| 89 | Steatorrhea (HP:0002570) | 2.27452084 |
| 90 | Alkalosis (HP:0001948) | 2.26053177 |
| 91 | Taurodontia (HP:0000679) | 2.25364627 |
| 92 | Abnormality of permanent molar morphology (HP:0011071) | 2.25364627 |
| 93 | Abnormality of the dental root (HP:0006486) | 2.25364627 |
| 94 | Late onset (HP:0003584) | 2.20305354 |
| 95 | Coronal craniosynostosis (HP:0004440) | 2.16212283 |
| 96 | Pterygium (HP:0001059) | 2.15074353 |
| 97 | Abnormal cartilage morphology (HP:0002763) | 2.13715237 |
| 98 | Chronic bronchitis (HP:0004469) | 2.13488643 |
| 99 | Renal tubular acidosis (HP:0001947) | 2.12094119 |
| 100 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.11810846 |
| 101 | Glycosuria (HP:0003076) | 2.09856642 |
| 102 | Abnormality of urine glucose concentration (HP:0011016) | 2.09856642 |
| 103 | Abnormality of molar (HP:0011077) | 2.09777729 |
| 104 | Abnormality of molar morphology (HP:0011070) | 2.09777729 |
| 105 | Right ventricular cardiomyopathy (HP:0011663) | 2.09721006 |
| 106 | Abnormality of the salivary glands (HP:0010286) | 2.09366843 |
| 107 | Abnormal ossification of hand bones (HP:0005921) | 2.09081795 |
| 108 | Down-sloping shoulders (HP:0200021) | 2.08994652 |
| 109 | Tibial bowing (HP:0002982) | 2.08451037 |
| 110 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.06695042 |
| 111 | Spontaneous abortion (HP:0005268) | 2.06568595 |
| 112 | Fragile skin (HP:0001030) | 2.05828518 |
| 113 | Dicarboxylic aciduria (HP:0003215) | 2.05794195 |
| 114 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.05794195 |
| 115 | Thick nail (HP:0001805) | 2.05596267 |
| 116 | Hepatoblastoma (HP:0002884) | 2.05473743 |
| 117 | Irritability (HP:0000737) | 2.05296630 |
| 118 | Protrusio acetabuli (HP:0003179) | 2.04856854 |
| 119 | Fragile nails (HP:0001808) | 2.04587344 |
| 120 | Menorrhagia (HP:0000132) | 2.03953328 |
| 121 | Abnormality of the gastric mucosa (HP:0004295) | 2.03304773 |
| 122 | Rickets (HP:0002748) | 2.03032048 |
| 123 | Glomerulonephritis (HP:0000099) | 2.02213903 |
| 124 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.01869249 |
| 125 | Abnormal hair laboratory examination (HP:0003328) | 2.01772774 |
| 126 | Abnormality of carpal bone ossification (HP:0006257) | 2.01574551 |
| 127 | Abnormality of serum amino acid levels (HP:0003112) | 2.01311447 |
| 128 | Recurrent bacterial skin infections (HP:0005406) | 2.00721533 |
| 129 | Vertebral arch anomaly (HP:0008438) | 2.00227310 |
| 130 | Gingival bleeding (HP:0000225) | 1.97895775 |
| 131 | Hypoplasia of dental enamel (HP:0006297) | 1.96761352 |
| 132 | Gastrointestinal infarctions (HP:0005244) | 1.96659033 |
| 133 | Cardiovascular calcification (HP:0011915) | 1.96585302 |
| 134 | Abnormality of the dental pulp (HP:0006479) | 1.96272354 |
| 135 | Absent eyelashes (HP:0000561) | 1.96231900 |
| 136 | Abdominal distention (HP:0003270) | 1.94842561 |
| 137 | Nephritis (HP:0000123) | 1.93778746 |
| 138 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.93499211 |
| 139 | Premature rupture of membranes (HP:0001788) | 1.92874629 |
| 140 | Skin nodule (HP:0200036) | 1.92303582 |
| 141 | Natal tooth (HP:0000695) | 1.91949298 |
| 142 | Bifid scrotum (HP:0000048) | 1.91875932 |
| 143 | Broad face (HP:0000283) | 1.91814206 |
| 144 | Acute hepatic failure (HP:0006554) | 1.91492151 |
| 145 | Amyloidosis (HP:0011034) | 1.91336500 |
| 146 | Hyperaldosteronism (HP:0000859) | 1.90708681 |
| 147 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.90513671 |
| 148 | Hypophosphatemia (HP:0002148) | 1.90342592 |
| 149 | Abnormality of chloride homeostasis (HP:0011422) | 1.89862663 |
| 150 | Plantar hyperkeratosis (HP:0007556) | 1.89008674 |
| 151 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.88407922 |
| 152 | Abnormal hand bone ossification (HP:0010660) | 1.88340483 |
| 153 | Thin bony cortex (HP:0002753) | 1.88122075 |
| 154 | Nephrolithiasis (HP:0000787) | 1.87279606 |
| 155 | Esophageal atresia (HP:0002032) | 1.87068513 |
| 156 | Lip pit (HP:0100267) | 1.86835605 |
| 157 | Onycholysis (HP:0001806) | 1.86702652 |
| 158 | Missing ribs (HP:0000921) | 1.86603844 |
| 159 | Pulmonary embolism (HP:0002204) | 1.86342466 |
| 160 | Lethargy (HP:0001254) | 1.85944422 |
| 161 | Decreased circulating renin level (HP:0003351) | 1.85900889 |
| 162 | Short nail (HP:0001799) | 1.85427943 |
| 163 | Abnormal vertebral ossification (HP:0100569) | 1.85335804 |
| 164 | Sparse lateral eyebrow (HP:0005338) | 1.85307621 |
| 165 | Metabolic alkalosis (HP:0200114) | 1.85260609 |
| 166 | Abnormal tarsal ossification (HP:0008369) | 1.84863771 |
| 167 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83902821 |
| 168 | Sensorimotor neuropathy (HP:0007141) | 1.83759591 |
| 169 | Subacute progressive viral hepatitis (HP:0006572) | 1.83482212 |
| 170 | Morphological abnormality of the middle ear (HP:0008609) | 1.82424225 |
| 171 | Vomiting (HP:0002013) | 1.81788161 |
| 172 | Shallow orbits (HP:0000586) | 1.80870042 |
| 173 | Selective tooth agenesis (HP:0001592) | 1.79519057 |
| 174 | Turricephaly (HP:0000262) | 1.79349919 |
| 175 | Focal segmental glomerulosclerosis (HP:0000097) | 1.76277506 |
| 176 | Thickened helices (HP:0000391) | 1.75427053 |
| 177 | Ulnar bowing (HP:0003031) | 1.74075993 |
| 178 | Genu recurvatum (HP:0002816) | 1.70908011 |
| 179 | Septate vagina (HP:0001153) | 1.70042522 |
| 180 | Multiple lipomas (HP:0001012) | 1.67829961 |
| 181 | Megalencephaly (HP:0001355) | 1.64910208 |
| 182 | Hyperacusis (HP:0010780) | 1.63483505 |
| 183 | Flattened epiphyses (HP:0003071) | 1.63100947 |
| 184 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.62486377 |
| 185 | Single umbilical artery (HP:0001195) | 1.62486377 |
| 186 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.62486377 |
| 187 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.60696747 |
| 188 | Breech presentation (HP:0001623) | 1.59548297 |
| 189 | Osteolytic defects of the hand bones (HP:0009699) | 1.59282976 |
| 190 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.59282976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.79527868 |
| 2 | MAP3K10 | 3.66575710 |
| 3 | ERN1 | 3.56209945 |
| 4 | TRIB3 | 3.14889939 |
| 5 | PKN2 | 2.98169948 |
| 6 | PNCK | 2.57745658 |
| 7 | MST1R | 2.49816451 |
| 8 | ERBB4 | 2.46615067 |
| 9 | LATS1 | 2.45491156 |
| 10 | STK24 | 2.31674515 |
| 11 | IRAK3 | 2.27953273 |
| 12 | TNIK | 2.22698525 |
| 13 | FRK | 2.20272632 |
| 14 | FGFR4 | 2.12613587 |
| 15 | SMG1 | 2.09494122 |
| 16 | STK39 | 2.01411378 |
| 17 | NTRK1 | 2.00828048 |
| 18 | TAOK3 | 1.94263273 |
| 19 | CASK | 1.92769222 |
| 20 | SIK1 | 1.92617500 |
| 21 | PTK6 | 1.86020838 |
| 22 | LMTK2 | 1.82695966 |
| 23 | WEE1 | 1.82292331 |
| 24 | MAP3K14 | 1.74444221 |
| 25 | CDK6 | 1.74437473 |
| 26 | TBK1 | 1.62365110 |
| 27 | ABL2 | 1.60983036 |
| 28 | RPS6KA4 | 1.49774498 |
| 29 | STK10 | 1.42355721 |
| 30 | MAP3K3 | 1.34162809 |
| 31 | RIPK4 | 1.27888339 |
| 32 | NEK1 | 1.27166075 |
| 33 | GRK6 | 1.27054976 |
| 34 | TXK | 1.24079484 |
| 35 | MAP3K9 | 1.23111952 |
| 36 | EPHA2 | 1.22323901 |
| 37 | BMX | 1.20300266 |
| 38 | INSRR | 1.19187697 |
| 39 | TYK2 | 1.18873631 |
| 40 | JAK2 | 1.17007512 |
| 41 | ICK | 1.14734545 |
| 42 | MAP4K1 | 1.14339456 |
| 43 | STK38L | 1.14028445 |
| 44 | MAP2K2 | 1.12635695 |
| 45 | PIK3CA | 1.10401424 |
| 46 | EPHB2 | 1.10350644 |
| 47 | CDK12 | 1.09563960 |
| 48 | CSK | 1.09122219 |
| 49 | EEF2K | 1.09082855 |
| 50 | MAPK11 | 1.08803609 |
| 51 | LRRK2 | 1.08047694 |
| 52 | TAF1 | 1.06590171 |
| 53 | MAP3K11 | 1.05588926 |
| 54 | CHUK | 1.05102248 |
| 55 | PIM1 | 1.04355797 |
| 56 | PBK | 1.03830082 |
| 57 | DMPK | 1.02938842 |
| 58 | FLT3 | 1.02046639 |
| 59 | ERBB2 | 1.01749741 |
| 60 | MST4 | 1.01393987 |
| 61 | GSK3A | 1.01256467 |
| 62 | WNK4 | 1.01015765 |
| 63 | BUB1 | 1.00005354 |
| 64 | AKT3 | 0.99415752 |
| 65 | FGFR3 | 0.98215275 |
| 66 | STK3 | 0.97873701 |
| 67 | ARAF | 0.94813380 |
| 68 | BCR | 0.92526608 |
| 69 | NEK9 | 0.92044753 |
| 70 | KDR | 0.91868781 |
| 71 | PIM2 | 0.91566560 |
| 72 | TSSK6 | 0.89586921 |
| 73 | TTK | 0.89305719 |
| 74 | MAP3K12 | 0.88208308 |
| 75 | TESK1 | 0.87699981 |
| 76 | RPS6KB2 | 0.85830137 |
| 77 | MAP3K5 | 0.84591597 |
| 78 | MARK3 | 0.83686632 |
| 79 | CDK4 | 0.82870695 |
| 80 | JAK3 | 0.82118192 |
| 81 | VRK2 | 0.81669295 |
| 82 | MAP3K2 | 0.81468693 |
| 83 | NME2 | 0.78860477 |
| 84 | MATK | 0.78160573 |
| 85 | PRKD3 | 0.77443151 |
| 86 | OXSR1 | 0.75392290 |
| 87 | YES1 | 0.74260567 |
| 88 | MAP2K3 | 0.73533871 |
| 89 | MKNK2 | 0.73522602 |
| 90 | IKBKB | 0.71947629 |
| 91 | ZAP70 | 0.71842726 |
| 92 | MAP3K6 | 0.71234050 |
| 93 | FGFR1 | 0.69714779 |
| 94 | RIPK1 | 0.67448330 |
| 95 | TGFBR2 | 0.67361762 |
| 96 | PTK2 | 0.66982389 |
| 97 | MAP3K8 | 0.66911790 |
| 98 | DYRK1B | 0.65488641 |
| 99 | IRAK4 | 0.65199054 |
| 100 | MET | 0.64794165 |
| 101 | EGFR | 0.64466512 |
| 102 | PRKCZ | 0.63494121 |
| 103 | LATS2 | 0.62868334 |
| 104 | WNK3 | 0.62393354 |
| 105 | MAPK4 | 0.62071161 |
| 106 | MOS | 0.59878467 |
| 107 | KSR2 | 0.59736775 |
| 108 | PDGFRA | 0.58977709 |
| 109 | MARK1 | 0.58335698 |
| 110 | BRAF | 0.57483756 |
| 111 | TRIM28 | 0.56484241 |
| 112 | BRSK2 | 0.56313921 |
| 113 | RPS6KA1 | 0.55638237 |
| 114 | MKNK1 | 0.55403925 |
| 115 | MTOR | 0.55090271 |
| 116 | ROCK2 | 0.54870972 |
| 117 | BMPR2 | 0.54832857 |
| 118 | TYRO3 | 0.54493386 |
| 119 | JAK1 | 0.53965613 |
| 120 | CDK7 | 0.51888520 |
| 121 | ACVR1B | 0.51686348 |
| 122 | ABL1 | 0.51336811 |
| 123 | PRKAA1 | 0.51314161 |
| 124 | LIMK1 | 0.50514081 |
| 125 | CAMK2D | 0.50072916 |
| 126 | BLK | 0.49990217 |
| 127 | TAOK1 | 0.49361335 |
| 128 | DYRK3 | 0.48928925 |
| 129 | MAP3K7 | 0.46829238 |
| 130 | IKBKE | 0.46569203 |
| 131 | MAPK15 | 0.46310009 |
| 132 | KSR1 | 0.45854857 |
| 133 | DDR2 | 0.45675547 |
| 134 | NEK6 | 0.45542894 |
| 135 | ILK | 0.45402634 |
| 136 | FER | 0.45036758 |
| 137 | SCYL2 | 0.44491622 |
| 138 | MELK | 0.43639794 |
| 139 | PRKACG | 0.43515123 |
| 140 | EPHA3 | 0.41851547 |
| 141 | PRKG2 | 0.41849665 |
| 142 | EPHB1 | 0.41822260 |
| 143 | PRKAA2 | 0.41337741 |
| 144 | NEK2 | 0.40968205 |
| 145 | PDGFRB | 0.40285803 |
| 146 | PAK4 | 0.39855513 |
| 147 | CAMK1G | 0.39047569 |
| 148 | MAP2K4 | 0.38510630 |
| 149 | CAMK2B | 0.38357658 |
| 150 | MAP2K1 | 0.37947022 |
| 151 | RPS6KA2 | 0.37647126 |
| 152 | PAK2 | 0.36969073 |
| 153 | CAMK2G | 0.36964898 |
| 154 | CDK9 | 0.35725123 |
| 155 | PRKCI | 0.35711563 |
| 156 | MAPKAPK5 | 0.35654403 |
| 157 | CDK18 | 0.34923031 |
| 158 | MAP3K1 | 0.34813615 |
| 159 | NME1 | 0.32770726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.14269875 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.67145073 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.58951001 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95202967 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.63861317 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.63087731 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62648462 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.47835179 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.33076841 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.28603128 |
| 11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.22762393 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.15416617 |
| 13 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.13383112 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.07513874 |
| 15 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.02491278 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.98363541 |
| 17 | Tight junction_Homo sapiens_hsa04530 | 1.96633501 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.94046762 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.89615932 |
| 20 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.88313994 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87304565 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86742799 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.81585973 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.80961757 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74429106 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73552743 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71184493 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71180072 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70528947 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.68524845 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.65136292 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.63337594 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.61811873 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.52751649 |
| 35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.51726321 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.51699051 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49650323 |
| 38 | Thyroid cancer_Homo sapiens_hsa05216 | 1.48617413 |
| 39 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.47112341 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.47076683 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.46072024 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.45297290 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.40986575 |
| 44 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.40803877 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40342242 |
| 46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.38507351 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.36878372 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36181179 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.36072749 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.33117652 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.32891200 |
| 52 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.31957970 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.19459192 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.17826397 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.17187281 |
| 56 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.11052290 |
| 57 | Axon guidance_Homo sapiens_hsa04360 | 1.09420255 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09403658 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 1.09368196 |
| 60 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.09033892 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.08664103 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07137878 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05147631 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02759342 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00558526 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99934180 |
| 67 | Prostate cancer_Homo sapiens_hsa05215 | 0.99054919 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.97750727 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95570503 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94946837 |
| 71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94832791 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94032571 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.93599050 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92755619 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.92296613 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91797808 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90344069 |
| 78 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.90035375 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89829189 |
| 80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.88898674 |
| 81 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.85535008 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84288060 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.83506481 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82595918 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81658825 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81482384 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80561194 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80099858 |
| 89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79564401 |
| 90 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.78191658 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.77781378 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.77610703 |
| 93 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.75041103 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73443632 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70912805 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69721864 |
| 97 | Melanogenesis_Homo sapiens_hsa04916 | 0.69337136 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.69267965 |
| 99 | Leishmaniasis_Homo sapiens_hsa05140 | 0.65262776 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64962952 |
| 101 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.62355043 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60150886 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59221963 |
| 104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58637950 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.57839729 |
| 106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57817170 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57051218 |
| 108 | Gap junction_Homo sapiens_hsa04540 | 0.55249703 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55113774 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54637804 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54371023 |
| 112 | Melanoma_Homo sapiens_hsa05218 | 0.54152945 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.50805315 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50762907 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46240444 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.45909894 |
| 117 | Cocaine addiction_Homo sapiens_hsa05030 | 0.45667464 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.43891239 |
| 119 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42155169 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41314408 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41186468 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41158261 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40923882 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40661608 |
| 125 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39393915 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38478970 |
| 127 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37177753 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35586317 |
| 129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34036633 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31117824 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.30943030 |
| 132 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.28355511 |
| 133 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.27565174 |
| 134 | Tuberculosis_Homo sapiens_hsa05152 | 0.25622516 |
| 135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23462630 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21584163 |
| 137 | Bladder cancer_Homo sapiens_hsa05219 | 0.21279977 |
| 138 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.19850614 |
| 139 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.18631320 |
| 140 | Hepatitis C_Homo sapiens_hsa05160 | 0.18376533 |
| 141 | Amoebiasis_Homo sapiens_hsa05146 | 0.18164150 |
| 142 | Adherens junction_Homo sapiens_hsa04520 | 0.16607042 |
| 143 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.16379028 |
| 144 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15776203 |
| 145 | Influenza A_Homo sapiens_hsa05164 | 0.12821924 |
| 146 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.12323384 |
| 147 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11193726 |
| 148 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.11019631 |
| 149 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.09101845 |
| 150 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06314577 |
| 151 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05625270 |
| 152 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.05244211 |
| 153 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.03113322 |
| 154 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.01811158 |

